WACCBIP Receives TIBA Rapid Impact Projects Award

The West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), has been awarded a £100,000 grant from the Tackling Infections to Benefit Africa (TIBA) partnership under its Rapid Impact Projects scheme. The grant is one of nine, £100,000 each, awarded to support proposed projects by TIBA’s African partners to capture the diverse challenges of healthcare systems in Africa.

The TIBA Ghana project will focus on the effects of Artemisinin-based combination therapy (ACT) on the dynamics of Plasmodium falciparum, Plasmodium malariae, and Plasmodium ovale infection in Ghana. The project will also feature several public engagement activities targeted at sensitising members of communities identified to have high prevalence of malaria.

Launching the project at a community engagement event in a low-income community in the Central Region of Ghana on February 23, Prof. Awandare reiterated WACCBIP’s commitment to investing in efforts towards the control, prevention, and treatment of malaria in Ghana. He assured residents of Ewim that the focus of the project would be of high relevance to their community, which records an estimated 124 cases of malaria every week.

“We try to organise events like this to explain to you what we are doing in the laboratory,” Prof. Awandare said. “We are trying to find more methods that are reliable in diagnosing malaria so that it doesn’t persist and harm you.”

Work on the TIBA Ghana project was given major impetus after an Advisory Group of local experts was constituted and a Terms of Reference adopted in February. The advisory group includes representatives from Ghana’s Ministry of Health, the Country Office of the World Health Organisation, and DFID in Ghana. Aside from progress on the research work itself, a community engagement event was organised for 25 April to coincide with World Malaria Day.

Contributed by WACCBIP communications